-
June 29, 2023 Elon Musk ‘Takes Ketamine to Manage Depression’, Report SaysElon Musk takes ketamine in small doses to treat depression and uses higher doses of...
-
June 27, 2023 The FDA Issues Guidance on Designing Psychedelic Clinical TrialsThe Food and Drug Administration published a new draft guidance with the purpose to advise...
-
June 26, 2023 Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction RecoveryIbogaine’s anti-addictive properties are known to work wonders on people struggling with various substances, such...
-
June 19, 2023 Ayahuasca May Have Aided in the Rescue of Children Lost in the Amazon ForestAyahuasca may have aided in finding four children lost in the Amazon jungle, following a...
-
June 13, 2023 Canadian Study Uncovers Significant Reductions in Substance Use After PsychedelicsA Canadian study found significant reductions in substance use after taking psychedelics, including alcohol and...
-
June 12, 2023 Montreal’s First Shroom Dispensary Is Set to Open in Less Than Three WeeksFunGuyz, an Ontario shroom shop chain, will open two new shroom dispensaries in Montreal this...
-
June 8, 2023 Healing for All: Warriors of Consciousness Making Ketamine Therapy AccessibleWarriors of Consciousness helps individuals struggling with anxiety, PTSD and depression to get access to...
-
June 6, 2023 Psychedelic Users Show Greater Psychological Strengths and Improved Well-being, Study FindsA new study published in the International Journal of Wellbeing, found that classical psychedelic users have...
-
June 1, 2023 The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked OffThe largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant...
-
May 30, 2023 Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer PatientsA single 25mg dose of psilocybin paired with psychological support has resulted in 57% of...
